(Q45419603)

14 December 2017

title

The genome of Epstein-Barr virus type 2 strain AG876. (English)

1 reference

14 December 2017

0 references

3

1 reference

14 December 2017

Aidan Dolan

1

1 reference

14 December 2017

Clare Addison

series ordinal

2

1 reference

14 December 2017

Andrew J Davison

series ordinal

4

1 reference

14 December 2017

Duncan J McGeoch

series ordinal

5

1 reference

14 December 2017

language of work or name

English

0 references

publication date

21 February 2006

1 reference

14 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Virology

1 reference

14 December 2017

volume

350

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

164-170

1 reference

Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

A cosmid-based system for constructing mutants of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Base-calling of automated sequencer traces using phred. II. Error probabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Base-calling of automated sequencer traces using phred. I. Accuracy assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

EBV gene expression in an NPC-related tumour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Molecular evolution of the gamma-Herpesvirinae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Novel intertypic recombinants of epstein-barr virus in the chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

A new tumour-derived transforming strain of Epstein–Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Geographical prevalence of two types of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

7 January 2021

inferred from DOI database lookup

Structural analyses of the Epstein-Barr virus BamHI A transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

7 January 2021

inferred from DOI database lookup

Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.015

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VIROL.2006.01.015

1 reference

14 December 2017

1 reference